Ask a Question

User toastgong5

Member for: 2 weeks (since Jul 2)
Type: Registered user
Full name:
Location:
About: Erlotinib therapy after initial us platinum doublet remedy in sufferers using EGFR crazy type non-small cellular lung cancer: results of a new mixed patient-level investigation NCIC CTG BR.21 years of age and also SATURN trials.

Activity by toastgong5

Score: 0 points
Title: Newbie
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

Wall for toastgong5

Please log in or register to post on this wall.
Snow Theme by Q2A Market
Powered by Question2Answer
...